No hay productos en el carrito



Pharmaceutical Biotechnology. Drug Discovery and Clinical Application
Kayser, O. — Warzecha, H.
2ª Edición Abril 2012
Inglés
Tapa dura
676 pags
3000 gr
17 x 22 x null cm
ISBN 9783527329946
Editorial WILEY
LIBRO IMPRESO
-5%
325,05 €308,80 €IVA incluido
312,55 €296,92 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
LIBRO ELECTRÓNICO
-5%
270,39 €256,87 €IVA incluido
259,99 €246,99 €IVA no incluido
Acceso On Line
Inmediato
Description
This is the second edition of a very successful book on Pharmaceutical Biotechnology. It is thoroughly updated; existing chapters have been completely re-written and the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world; the second edition does now cover not only biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. The content has been thoroughly updated and greatly expanded (100% more content). As with the previous edition, quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are covered as well.
Table of contents
Preface
PART I: CONCEPTS AND METHODS FOR RECOMBINANT DRUG PRODUCTION
Pharmaceutical Biotechnology and Industrial Applications: Learning Lessons from
Molecular Biology (Oliver Kayser, Heribert Warzecha)
Procaryotic Cells in Biotech Production (Andriy Luzhetskyy, Gabriele Weitnauer,
Andreas Bechtold)
Mammalian Cells in Biotech Production (Maria J. De Jesus and Florian M. Wurm)
Biopharmaceuticals from Plants (Heribert Warzecha)
The Production of Biopharmaceuticals in Transgenic Animals (Heiner Niemann,
Alexander Kind, Angelika Schnieke)
Translation of New Technologies in Biomedicines: Shaping the Road from Basic
Research to Drug Development and Clinical Application - and Back Again (Michael
Balls, Andrew Bennett, David Kendall)
PART II: BRINGING THE DRUG INTO ACTION - FROM DOWNSTREAMING TO APPROVAL
Overview and Classification of Approved Recombinant Drugs (Theo Dingermann,
I. Zündorf)
Downstream Processing (Uwe Gottschalk)
Characterization of Recombinant Proteins (Christoph Giese, Henning von Horsten,
Stefan Zietze)
Formulation Strategies for Recombinant Protein and Related Biotech Drugs (Gerhard
Winter, Julia Myschik)
Drug Approval in the European Union and United States (Gary Walsh)
Patents in the Pharmaceutical Biotechnology Industry: Legal and Ethical Issues
(David B. Resnick)
Biosimilar Drugs (Walter Hinderer)
Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins (Yi
Zhang, Bernd Meibohm)
PART III: VACCINES
Scientific, Technical and Economic Aspects of Vaccine Research and Development
(Jens Peter Gregersen)
New Nanobiotechnological Strategies for the Development of Vectors for Cancer
Vaccines (Sean M. Geary, Caitlin D. Lemke, Yogita Krishnamachari, Aliasger K.
Salem)
Recombinant Vaccines: Development, Production and Application (Luke Richard
Le Grand
Michaela White, Evan B. Siegel, Ross Thomas Barnard)
PART IV: RECENT APPLICATIONS IN PHARMACEUTICAL BIOTECHNOLOGY
In Silico and Ultra-high Throughput Screenings (uHTS) in Drug Discovery: An
Overview (Debmalya Barh, Shoaib Ahmad, Atanu Bhattacharjee)
Metabolic Engineering of Medicinal Plants and Microorganisms for the Production
of Natural Products (O Kayser, J Hille, HJ Woerdenbag)
Metabolomics as Bioanalytical Tool for Characterization of Medicinal Plants
and their Phytomedical Preparations (Nizar Happyana, Remco Muntendam, Oliver
Kayser)
Integration of Biotechnologies for the Development of Personalized Medicine
(Kewal Jain)
Xenotransplantation in Pharmaceutical Biotechnology (Gregory J. Brunn and Jeffrey
L. Platt)
Nutraceuticals/Functional Foods for Improving Health and Preventing Disease
(Jian Zhao)
Index
Autor
Oliver Kayser: Oliver Kayser received his PhD at the Free University Berlin in 1997 following his fellowship at the University of Gainesville, Florida, whereupon he entered the pharmaceutical biotechnology industry. He is currently a lecturer at the Department of Pharmaceutics, Biopharmacy and Biotechnology at the FU Berlin, working on new biotech drugs from natural sources and on the development of drug delivery carriers based on nanosuspension and solid lipid nanoparticle enterprise technologies.
Prof. Dr. Heribert Warzecha
Studied Pharmazie at the Johannes Gutenberg-Universität, Mainz. After completing
his Ph.D. in 1998, he worked first as a postdoctoral fellow at Cornell, USA,
and become associate Professor in würzburg in 2001. Since 2007 he is full
Professor at the technical university of Darmstadt and became dean of the Institute
of plant science in 2009.
© 2025 Axón Librería S.L.
2.149.0